Among these, use of lactoferrin as a promising dietary supplement had been considered, however, the effectiveness of lactoferrin to prevent LOS and NEC in preterm infants and its safety was regarded as controversial. The gene discussed is LTF; the disease is necrotizing enterocolitis.